IBM CEO Arvind Krishna is drawing a clear line between market volatility and long-term industrial value. During a recent interview, Krishna addressed concerns about Q2 capital spending delays, stating that 40% of those deferred projects returned within weeks. He maintains that these represent pauses rather than a collapse in demand. Beyond the near-term noise, the focus is squarely on the emergence of quantum computing.
Krishna expects quantum technology to generate measurable financial results by 2028 or 2029. He projected that by the end of the 2030s, the technology will reach a valuation of one trillion dollars. This timeline is supported by recent experimental successes. IBM researchers, working with partners like Algorithmiq and the University of Chicago, successfully demonstrated quantum advantage by solving complex problems that remain intractable for classical supercomputers.
To secure this future, IBM is committing over $10 billion to quantum research over the next five years. This includes the development of the first purpose-built quantum wafer foundry in the United States, backed by a $2 billion investment split with federal incentives. While competitors are active in the space, IBM possesses a unique combination of established enterprise relationships and in-house manufacturing capabilities that separates it from other players.
Investors currently pricing the stock as a legacy software and consulting business may be missing the second chapter of the company. With the CEO now putting hard dates and dollar figures on a potential trillion-dollar market, the strategy is less about speculation and more about long-term execution. The company continues its long-standing commitment to shareholders, maintaining an unbroken streak of quarterly dividends dating back to 1916.